Trial survey of alpha-interferon effect on 16 patients with chronic viral hepatitis

Trial survey of alpha-interferon effect on 16 patients with chronic viral hepatitis

Alpha-interferon therapy has been approved for treatment of chronic hepatitis C and B. Candidates for treatment are patients with well-compensated liver disease and histologic evidences of chronic hepatitis who have demonstrated abnormal aminotransferase levels for more than 6 months. From 30 patien...

Full description

Bibliographic Details
Main Authors:	Daryani N, Samar G, Yalda A
Format:	Article
Language:	fas
Published:	Tehran University of Medical Sciences 1995-04-01
Series:	Tehran University Medical Journal
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5937.pdf&manuscript_id=5937

Similar Items

Lichen planus exacerbation by interferon - alpha - 2A for chronic viral hepatitis C
by: Al Ghamdi Abdullah, et al.
Published: (2000-01-01)

Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis
by: Yi-Wen Huang, et al.
Published: (2022-05-01)

Regression of alveolar echinococcosis after chronic viral hepatitis C treatment with pegylated interferon alpha 2a
by: Dražilová S., et al.
Published: (2012-09-01)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
by: Marina V. Mayevskaya, et al.
Published: (2018-08-01)

Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
by: Ming-Lun Yeh, et al.
Published: (2015-01-01)

Effectiveness of alpha interferon (+ ribavirin) in the treatment of chronic viral hepatitis C genotypes 2 and 3 in a brazilian sample
by: Candice Beatriz Treter Gonçalves, et al.
Published: (2012-06-01)

Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
by: Luis Jesuino de Oliveira Andrade, PhD, et al.
Published: (2011-07-01)

Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
by: Luis Jesuino de Oliveira Andrade, et al.

Interferon-based Simeprevir Therapy for Pediatric Patients with Chronic Hepatitis C Viral Infection
by: Mitsuyoshi Suzuki, et al.
Published: (2018-09-01)

PREVALENCE OF SIDE EFFECTS OF INTERFERON THERAPY IN CHILDREN WITH CHRONIC VIRAL HEPATITIS C
by: T. A. Skvortsova, et al.
Published: (2013-05-01)

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
by: Riva Elisabetta, et al.
Published: (2010-11-01)

The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C
by: Maryam Keshvari, et al.
Published: (2016-01-01)

Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
by: Yisi Liu, et al.
Published: (2023-05-01)

Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C
by: June Seok Song, et al.
Published: (2016-05-01)

De novo Cryoglobulinaemic Mononeuritis Multiplex during Treatment of Chronic Hepatitis C Infection: A Viral Effect or Induced by Pegylated Interferon Alpha
by: J.R. Potts, et al.
Published: (2012-03-01)

Interferon alpha induces sustained changes in NK cell responsiveness to Hepatitis B viral load suppression in vivo.
by: Gill, US, et al.
Published: (2016)

Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.
by: Upkar S Gill, et al.
Published: (2016-08-01)

Intrinsic Viral Factors Are the Dominant Determinants of the Hepatitis C Virus Response to Interferon Alpha Treatment in Chimeric Mice.
by: Ran Chen, et al.
Published: (2016-01-01)

Response of Hepatitis C Patients to Alpha Interferon and Ribavirin Combination Therapy
by: Ihsanullah Mahsud, et al.
Published: (2004-06-01)

Histological response study of chronic viral hepatitis C patients treated with interferon alone or combined with ribavirin
by: Kleber Prado, et al.

INTERFERON-ALPHA(IFN-ALPHA) PROLONGS SURVIVAL FOR PATIENTS WITH CML IN CHRONIC PHASE - PRELIMINARY-RESULTS OF THE UK MRC RANDOMIZED MULTICENTER TRIAL
by: Allan, N, et al.
Published: (1994)

Effects of interferon therapy onfunctional activity of platelets in chronic viral hepatitis andcirrhosis of the liver
by: A V Yagoda, et al.
Published: (2004-08-01)

Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c
by: BSE August-Jörg, et al.
Published: (2003-08-01)

A Comparison of Interferon-Alpha-2b Induction Therapy with Interferon-Alpha-2b Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
by: Bilgehan AYGEN, et al.
Published: (2004-09-01)

Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B
by: Li H, et al.
Published: (2018-05-01)

Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin
by: Jafroodi M, et al.
Published: (2011-07-01)

A meta-analysis of patients with chronic hepatitis C treated with interferon-alpha to determine the risk of autoimmune thyroiditis
by: Luis Jesuino de Oliveira Andrade, et al.
Published: (2011-01-01)

Sonographic changes of liver and gallbladder in acute viral hepatitis
by: Ebrahimi Daryani N, et al.
Published: (2001-07-01)

Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
by: Gliga Smaranda, et al.
Published: (2011-03-01)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
by: Yasser K. Rashed, et al.
Published: (2020-02-01)

Response to treatment with interferon-alpha and ribavirin in patients with chronic Hepatitis C virus genotypes 2 and 3 depends on the degree of hepatic fibrosis
by: Edison Roberto Parise, et al.

ASSOCIATIONS OF INTERFERON GENE POLYMORPHISMS OAS-1, OAS-3, PKR WITH CHRONIC VIRAL HEPATITIS C
by: V. A. Bychkov, et al.
Published: (2014-07-01)

Interferon-alpha: results from randomized trials.
by: Richards, S
Published: (1997)

Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferon-alpha and ribavirin: A prospective study
by: Ružić Maja, et al.
Published: (2017-01-01)

Efficacy of triple therapy with interferon alpha-2b, ribavirin and amantadine in the treatment of naïve patients with chronic hepatitis C
by: Hamid Kalantari, et al.
Published: (2007-08-01)

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
by: Nishikawa Hiroki, et al.
Published: (2012-03-01)

Evaluation of Response to Interferon Therapy in Chronic Hepatitis B and Chronic Hepatitis C Patients
by: Hakan LEBLEBİCİOĞLU, et al.
Published: (2001-09-01)

Interferon alpha-2b and ribavirin as combined therapy for chronic hepatitis C in Cuba: National Program
by: Hugo Nodarse-Cuní, et al.

Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon alpha
by: Magdalena Góra-Gębka, MD, PhD, et al.
Published: (2003-04-01)

CHRONIC FATIGUE IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: Tatyana Vasiliyevna Polukchi
Published: (2022-08-01)